The 10-second takeaway
For the quarter ended Dec. 31 (Q1), Amdocs met expectations on revenue and missed expectations on earnings per share.
Compared to the prior-year quarter, revenue increased and GAAP earnings per share increased significantly.
Margins expanded across the board.
Amdocs reported revenue of $807.0 million. The 14 analysts polled by S&P Capital IQ predicted sales of $816.1 million. Sales were 4.1% higher than the prior-year quarter's $775.2 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions.
Non-GAAP EPS came in at $0.57. The eight earnings estimates compiled by S&P Capital IQ forecast $0.61 per share on the same basis. GAAP EPS of $0.53 for Q1 were 39% higher than the prior-year quarter's $0.38 per share.
Source: S&P Capital IQ. Quarterly periods. Figures may be non-GAAP to maintain comparability with estimates.
For the quarter, gross margin was 35.9%, 150 basis points better than the prior-year quarter. Operating margin was 13.5%, 220 basis points better than the prior-year quarter. Net margin was 11.5%, 200 basis points better than the prior-year quarter.
Next quarter's average estimate for revenue is $819.2 million. On the bottom line, the average EPS estimate is $0.59.
Next year's average estimate for revenue is $3.35 billion. The average EPS estimate is $2.49.
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 200 members out of 211 rating the stock outperform, and 11 members rating it underperform. Among 72 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 70 give Amdocs a green thumbs-up, and two give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Amdocs is outperform, with an average price target of $34.36.
Is Amdocs playing the right part in the new technology revolution? Computers, mobile devices, and related services are creating huge amounts of valuable data, but only for companies that can crunch the numbers and make sense of it. Meet the leader in this field in "The Only Stock You Need To Profit From the NEW Technology Revolution." Click here for instant access to this free report.
- Add Amdocs to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.